IL80895A - Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it - Google Patents

Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it

Info

Publication number
IL80895A
IL80895A IL80895A IL8089583A IL80895A IL 80895 A IL80895 A IL 80895A IL 80895 A IL80895 A IL 80895A IL 8089583 A IL8089583 A IL 8089583A IL 80895 A IL80895 A IL 80895A
Authority
IL
Israel
Prior art keywords
herpes simplex
simplex virus
vaccine composition
immunologically active
envelope glycoprotein
Prior art date
Application number
IL80895A
Other languages
English (en)
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26996451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL80895(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of IL80895A publication Critical patent/IL80895A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL80895A 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it IL80895A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35002182A 1982-02-18 1982-02-18
US06/463,141 US4762708A (en) 1982-02-18 1983-02-04 Materials and methods for herpes simplex virus vaccination
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it

Publications (1)

Publication Number Publication Date
IL80895A true IL80895A (en) 1990-02-09

Family

ID=26996451

Family Applications (5)

Application Number Title Priority Date Filing Date
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it
IL80896A IL80896A (en) 1982-02-18 1983-02-16 Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them
IL80895A IL80895A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A0 (en) 1982-02-18 1986-12-07 Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Family Applications Before (2)

Application Number Title Priority Date Filing Date
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it
IL80896A IL80896A (en) 1982-02-18 1983-02-16 Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL80895A IL80895A0 (en) 1982-02-18 1986-12-07 Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Country Status (20)

Country Link
US (1) US4762708A (da)
EP (1) EP0101506B1 (da)
JP (3) JP2665332B2 (da)
KR (1) KR910006889B1 (da)
AR (1) AR231496A1 (da)
AT (1) ATE54827T1 (da)
AU (1) AU554710B2 (da)
CA (1) CA1236774A (da)
DE (1) DE3381761D1 (da)
DK (1) DK172619B1 (da)
ES (1) ES519875A0 (da)
FI (2) FI73885C (da)
GR (1) GR77900B (da)
HU (1) HU195734B (da)
IE (1) IE56479B1 (da)
IL (5) IL67930A (da)
NO (2) NO162366B (da)
NZ (1) NZ220771A (da)
PH (1) PH25689A (da)
WO (1) WO1983002897A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
EP0203676B1 (en) * 1985-04-19 1992-01-29 The Wistar Institute Of Anatomy And Biology Vaccine for generating an immunogenic t cell response protective against a virus
GB8605390D0 (en) * 1986-03-05 1986-04-09 Univ Birmingham Live herpes simplex vaccine
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US5654174A (en) * 1995-07-07 1997-08-05 Competitive Technologies, Inc. Herpes simplex virus glycoprotein D variants
US20020090382A1 (en) * 2000-08-01 2002-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Antiviral compounds and methods
US20030219448A1 (en) * 2002-05-24 2003-11-27 Cedars-Sinai Medical Center Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases
ATE414176T1 (de) * 2002-07-18 2008-11-15 Univ Washington Schnelle, effiziente reinigung von hsv- spezifischen t-lymphozyten und damit identifizierte hsv-antigene
EP1670507A4 (en) * 2003-09-12 2007-10-17 Antigenics Inc VACCINE FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY HERPES SIMPLEX VIRUS
CA2663109A1 (en) * 2006-09-08 2008-03-13 The Trustees Of The University Of Pennsylvania Hsv-1 and hsv-2 vaccines and methods of use thereof
US8865185B2 (en) 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
US20130028925A1 (en) * 2006-12-28 2013-01-31 Harvey Friedman Herpes simplex virus combined subunit vaccines and methods of use thereof
CA2674051C (en) * 2006-12-28 2017-10-31 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US8057804B2 (en) * 2006-12-28 2011-11-15 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US10478490B2 (en) * 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
WO2011106607A2 (en) 2010-02-26 2011-09-01 Juvaris Biotherapeutics, Inc. Subunit vaccines for herpes viruses and methods of use
EP2694542A4 (en) * 2011-04-08 2014-10-08 Univ Duke HERPES SIMPLEX VIRUS
LT2850431T (lt) 2012-05-16 2018-06-25 Immune Design Corp. Vakcinos, skirtos hsv-2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
JP2530801B2 (ja) * 1978-12-22 1996-09-04 バイオゲン インコーポレイテッド 組換えｄｎａ分子

Also Published As

Publication number Publication date
FI83880B (fi) 1991-05-31
NO842962L (no) 1983-10-17
PH25689A (en) 1991-09-04
HU195734B (en) 1988-07-28
FI833768A (fi) 1983-10-17
ATE54827T1 (de) 1990-08-15
IL67930A0 (en) 1983-06-15
IL80895A0 (en) 1987-03-31
NO172745C (no) 1993-09-01
ES8406199A1 (es) 1984-08-01
FI83880C (fi) 1991-09-10
EP0101506B1 (en) 1990-07-25
ES519875A0 (es) 1984-08-01
FI73885C (fi) 1987-12-10
FI864102A0 (fi) 1986-10-10
JP2669594B2 (ja) 1997-10-29
IL67930A (en) 1990-02-09
CA1236774A (en) 1988-05-17
FI73885B (fi) 1987-08-31
IL80896A0 (en) 1987-03-31
NO172745B (no) 1993-05-24
AU554710B2 (en) 1986-08-28
NZ220771A (en) 1990-09-26
JP2567202B2 (ja) 1996-12-25
EP0101506A4 (en) 1984-07-06
IL80896A (en) 1990-02-09
KR910006889B1 (ko) 1991-09-10
WO1983002897A1 (en) 1983-09-01
NO162366B (no) 1989-09-11
EP0101506A1 (en) 1984-02-29
AR231496A1 (es) 1984-12-28
DK172619B1 (da) 1999-03-01
IE56479B1 (en) 1991-08-14
DK479083A (da) 1983-10-17
JP2665332B2 (ja) 1997-10-22
JPH0797396A (ja) 1995-04-11
JPH0769924A (ja) 1995-03-14
NO833773L (no) 1983-10-17
DK479083D0 (da) 1983-10-17
GR77900B (da) 1984-09-25
FI864102A (fi) 1986-10-10
IE830332L (en) 1983-08-18
AU1339683A (en) 1983-09-08
KR840003420A (ko) 1984-09-08
DE3381761D1 (de) 1990-08-30
FI833768A0 (fi) 1983-10-17
JPS59500216A (ja) 1984-02-16
US4762708A (en) 1988-08-09

Similar Documents

Publication Publication Date Title
IL80895A (en) Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it
GB2246784B (en) Herpes virus recombinant poxvirus vaccine
JPS6425800A (en) T-cell epitope of hepatities b virus nucleocapside protein
IL84154A0 (en) Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
NZ220612A (en) 11 residue influenza virus peptide and vaccines
AU1255383A (en) Foot and mouth disease viral antigenic peptides
GR860987B (en) Antigens of the glycoprotein of the aids virus envelope specially of the glycoprotein precursors methods for obtaining these antigens means therefor and their applications
IL79954A0 (en) Attenuated pseudorabies virus and vaccine containing same
NZ203190A (en) Vaccines of infections bronchitis virus
NZ183907A (en) Attenuated live equine herpes i (equine rhinopneumonitis) virus and vaccine
JPS5726624A (en) Isolation of virus glycoprotein antigen and manufacture of vaccine thereby
HK79890A (en) Prophylactic and therapeutic use of muramyl peptides and their analogues against viral infections
IL60370A0 (en) Polyvalent virus vaccine and its preparation
GB8728000D0 (en) Immunologically active polypeptides useful for preparation of antimalarial vaccines and of diagnostic kits
DE2964881D1 (en) Parainfluenza virus vaccine and its preparation
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
IE860983L (en) Antigens related to envelope glycoprotein of the virus of¹aids
GB8630851D0 (en) Babesia divergens antigen & vaccine
GB8729976D0 (en) Polypeptide composition useful for preparation of antimalarial vaccines
AU553932B2 (en) Vaccine against herpes virus vaccine
ZA831097B (en) Materials and methods for herpes simplex virus vaccination
ZA88552B (en) Hiv gp160 aids virus envelope protein-containing strips and use thereof for detection of aids antibody
GB8608991D0 (en) Virus vaccine
GR3003377T3 (en) Virus vaccine
GB8712042D0 (en) Virus & vaccine

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired